Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)
24.73
+2.25 (10.01%)
Jan 23, 2026, 3:00 PM CST
SHA:605016 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2016 - 2020 |
Operating Revenue | 1,379 | 1,107 | 854.14 | 696.18 | 638.52 | Upgrade |
Other Revenue | - | 45 | 14.12 | 25.71 | 14.83 | Upgrade |
| 1,379 | 1,152 | 868.26 | 721.89 | 653.36 | Upgrade | |
Revenue Growth (YoY) | 19.75% | 32.64% | 20.28% | 10.49% | 30.77% | Upgrade |
Cost of Revenue | - | 764.89 | 584.2 | 493.41 | 471.72 | Upgrade |
Gross Profit | 1,379 | 386.76 | 284.06 | 228.49 | 181.64 | Upgrade |
Selling, General & Admin | - | 67.54 | 47.77 | 45.05 | 40.35 | Upgrade |
Research & Development | - | 44.46 | 32.56 | 27.03 | 23.26 | Upgrade |
Other Operating Expenses | 946.84 | 9.68 | 7.61 | 5.99 | 5.67 | Upgrade |
Operating Expenses | 946.84 | 127.92 | 90.61 | 82.81 | 71.65 | Upgrade |
Operating Income | 432.22 | 258.84 | 193.45 | 145.68 | 109.98 | Upgrade |
Interest Expense | - | -2.66 | -2.25 | -0.07 | -1.04 | Upgrade |
Interest & Investment Income | - | 9.61 | 12.14 | 12.76 | 5.04 | Upgrade |
Currency Exchange Gain (Loss) | - | 8.17 | 4.13 | 10.28 | -2.76 | Upgrade |
Other Non Operating Income (Expenses) | -0.58 | -0.43 | -0.21 | -0.13 | -0.14 | Upgrade |
EBT Excluding Unusual Items | 431.63 | 273.53 | 207.27 | 168.52 | 111.09 | Upgrade |
Gain (Loss) on Sale of Investments | - | 1.27 | 2.7 | 0 | 3.35 | Upgrade |
Gain (Loss) on Sale of Assets | - | -0.39 | -2.13 | -3.15 | -1.26 | Upgrade |
Asset Writedown | - | - | - | - | -1.73 | Upgrade |
Other Unusual Items | - | 10.89 | 13.68 | 7.71 | 7.32 | Upgrade |
Pretax Income | 431.63 | 285.31 | 221.52 | 173.09 | 118.77 | Upgrade |
Income Tax Expense | 65.85 | 39.71 | 28.52 | 22.34 | 14.29 | Upgrade |
Net Income | 365.78 | 245.6 | 193 | 150.75 | 104.48 | Upgrade |
Net Income to Common | 365.78 | 245.6 | 193 | 150.75 | 104.48 | Upgrade |
Net Income Growth | 48.94% | 27.26% | 28.02% | 44.29% | 9.34% | Upgrade |
Shares Outstanding (Basic) | 420 | 420 | 418 | 418 | 385 | Upgrade |
Shares Outstanding (Diluted) | 420 | 420 | 418 | 418 | 385 | Upgrade |
Shares Change (YoY) | 0.08% | 0.46% | 0.12% | 8.63% | 22.70% | Upgrade |
EPS (Basic) | 0.87 | 0.58 | 0.46 | 0.36 | 0.27 | Upgrade |
EPS (Diluted) | 0.87 | 0.58 | 0.46 | 0.36 | 0.27 | Upgrade |
EPS Growth | 48.82% | 26.67% | 27.88% | 32.83% | -10.89% | Upgrade |
Free Cash Flow | - | 19.09 | -117.34 | -25.78 | 40.38 | Upgrade |
Free Cash Flow Per Share | - | 0.04 | -0.28 | -0.06 | 0.10 | Upgrade |
Dividend Per Share | - | 0.146 | 0.142 | 0.072 | 0.026 | Upgrade |
Dividend Growth | - | 2.96% | 97.50% | 180.86% | - | Upgrade |
Gross Margin | 100.00% | 33.58% | 32.72% | 31.65% | 27.80% | Upgrade |
Operating Margin | 31.34% | 22.48% | 22.28% | 20.18% | 16.83% | Upgrade |
Profit Margin | 26.52% | 21.33% | 22.23% | 20.88% | 15.99% | Upgrade |
Free Cash Flow Margin | - | 1.66% | -13.51% | -3.57% | 6.18% | Upgrade |
EBITDA | 507.6 | 334.22 | 238.38 | 192.42 | 156.51 | Upgrade |
EBITDA Margin | 36.81% | 29.02% | 27.46% | 26.66% | 23.96% | Upgrade |
D&A For EBITDA | 75.38 | 75.38 | 44.93 | 46.75 | 46.53 | Upgrade |
EBIT | 432.22 | 258.84 | 193.45 | 145.68 | 109.98 | Upgrade |
EBIT Margin | 31.34% | 22.48% | 22.28% | 20.18% | 16.83% | Upgrade |
Effective Tax Rate | 15.26% | 13.92% | 12.88% | 12.91% | 12.04% | Upgrade |
Revenue as Reported | - | 1,152 | 868.26 | 721.89 | 653.36 | Upgrade |
Advertising Expenses | - | 3.48 | 2.9 | 1.13 | 1.25 | Upgrade |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.